Illumina, Inc. Profile Avatar - Palmy Investing

Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications i…
Medical - Diagnostics & Research
US, San Diego [HQ]
ILMN/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
666.00 902.00 1,055.00 1,148.00 1,421.00 1,861.00 2,219.00 2,398.00 2,752.00 3,333.00 3,543.00 3,239.00 4,526.00 4,584.00 4,504.00
EPS
0.59 1.01 0.70 1.23 1.00 2.61 3.18 3.15 4.97 5.62 6.82 4.46 5.08 -28.05 -7.35
Profit
460.00 601.00 709.00 773.00 911.00 1,297.00 1,549.00 1,666.00 1,826.00 2,300.00 2,467.00 2,203.00 3,154.00 2,972.00 2,750.00
Pre Tax
114.00 185.00 133.00 222.00 159.00 448.00 583.00 561.00 1,043.00 894.00 1,118.00 856.00 884.00 -4,336.00 -1,117.00
ETR
36.67 32.63 34.89 32.05 21.35 21.26 21.56 23.72 35.00 12.53 11.45 23.36 13.80 -1.57 -3.94
Net
72.00 124.00 86.00 151.00 125.00 353.00 461.00 462.00 726.00 826.00 1,002.00 656.00 762.00 -4,404.00 -1,161.00
EBITDA
154.00 237.00 283.00 312.00 374.00 372.00 633.00 571.00 606.00 883.00 985.00 580.00 -123.00 4,887.00 362.00
Operating Income
125.00 211.00 199.00 200.00 134.00 514.00 612.00 587.00 606.00 883.00 985.00 580.00 -123.00 -4,179.00 -70.00
Interest Income
11.00 8.00 7.00 16.00 4.00 3.00 5.00 9.00 19.00 44.00 75.00 41.00 61.00 11.00 58.00
Loss
-529.00 -691.00 -847.00 -892.00 -1,167.00 -1,417.00 -1,596.00 -1,819.00 -2,146.00 -2,450.00 -2,558.00 -2,659.00 -4,649.00 -4,230.00 -4,574.00
Cost of Revenue
-205.00 -301.00 -346.00 -374.00 -509.00 -563.00 -670.00 -731.00 -926.00 -1,033.00 -1,076.00 -1,036.00 -1,372.00 -1,612.00 -1,754.00
Operating Expenses
-323.00 -389.00 -500.00 -517.00 -657.00 -854.00 -926.00 -1,087.00 -1,220.00 -1,417.00 -1,482.00 -1,623.00 -3,277.00 -2,618.00 -2,820.00
Depreciation and Amortization
-31.00 -42.00 -68.00 -63.00 -97.00 -112.00 -126.00 -140.00 -156.00 -179.00 -188.00 -187.00 -251.00 -394.00 -432.00
Interest Expenses
-23.00 -24.00 -34.00 -37.00 -39.00 -41.00 -42.00 -33.00 -37.00 -57.00 -52.00 -49.00 -61.00 -26.00 -77.00
Other Expenses
-11.00 -26.00 -75.00 -33.00 -25.00 -65.00 -39.00 -25.00 -437.00 -11.00 -133.00 -276.00 -1,007.00 -157.00 -1,047.00
WA Shares Outstanding
123.00 123.00 123.00 122.00 125.00 135.00 145.00 147.00 146.00 147.00 147.00 147.00 150.00 157.00 158.00
End of ILMN's Analysis
CIK: 1110803 CUSIP: 452327109 ISIN: US4523271090 LEI: - UEI: -
Secondary Listings